Home  |  Contact

UniProtKB/Swiss-Prot Q9GZX7: Variant p.His130Pro

Single-stranded DNA cytosine deaminase
Gene: AICDA
Variant information

Variant position:  130
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Histidine (H) to Proline (P) at position 130 (H130P, p.His130Pro).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (H) to medium size and hydrophobic (P)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HIGM2; slightly decreased mutagenic activity.
Any additional useful information about the variant.



Sequence information

Variant position:  130
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  198
The length of the canonical sequence.

Location on the sequence:   TARLYFCEDRKAEPEGLRRL  H RAGVQIAIMTFKDYFYCWNT
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TARLYFCE-DRKAEPEGLRRLHRAGVQIAIMTFKDYFYCWNT

                              AARLYFCE-DRKAEPEGLRRLHRAGVQIAIMTFKDYFYCWN

Mouse                         TARLYFCE-DRKAEPEGLRRLHRAGVQIGIMTFKDYFYCWN

Bovine                        TARLYFCDKERKAEPEGLRRLHRAGVQIAIMTFKDYFYCWN

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 198 Single-stranded DNA cytosine deaminase
Mutagenesis 112 – 112 R -> D. Greatly reduced nuclear import; when associated with A-193.
Helix 122 – 132


Literature citations

Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H.; Ben-Mustapha I.; Ben-ali M.; Ben-khemis L.; Largueche B.; Boussoffara R.; Maalej S.; Fetni I.; Hassayoun S.; Mahfoudh A.; Mellouli F.; Yalaoui S.; Masmoudi H.; Bejaoui M.; Barbouche M.R.;
Immunogenetics 68:19-28(2016)
Cited for: VARIANTS HIGM2 HIS-31 AND PRO-130;

Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H.; Ben-Mustapha I.; Ben-Ali M.; Largueche B.; Jovanic T.; Garcia S.; Arcangioli B.; Elloumi-Zghal H.; Fathallah D.; Hachicha M.; Masmoudi H.; Rougeon F.; Barbouche M.R.;
Mol. Immunol. 79:77-82(2016)
Cited for: CHARACTERIZATION OF VARIANTS HIGM2 TYR-56 AND PRO-130; FUNCTION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.